Summer camp: What parents need to know this year

Many parents and children hope that this summer will allow a return to typical activities. For families who are considering summer camp for their children, adjustments and adaptations will need to be made because of COVID-19, and parents should be prepared to ask questions about planning and risk management.

Content restricted. Requires subscription

Harvard Health Ad Watch: Mitochondria do a lot for you — what can you do for them?

Mitochondria are the power stations in our cells that convert nutrients into energy, and research suggests that they play a key role in aging and immune function. Ads for a line of supplements claim that the product renews or replenishes mitochondria –– but is there any scientific proof of this?

Content restricted. Requires subscription

Simple, low-cost, low-tech brain training

Mentally stimulating activities help the brain create new connections that may prevent cognitive decline as people get older, and there are plenty of simple, low-tech ways to sharpen your thinking that are budget-friendly.

Content restricted. Requires subscription

School reopening? What parents need to know and can do

While some children have been attending school in-person throughout the pandemic, most have been learning remotely, or in a hybrid model. As more schools reopen for in-person learning, parents can ask key questions about their school district’s plans and help their children prepare to go back.

Content restricted. Requires subscription

Omega-3 fatty acids and the heart: New evidence, more questions

Omega-3 fatty acids from fish and fish oil have been recommended by the American Heart Association for the past 20 years to reduce cardiovascular events in people who already have cardiovascular disease. But the results of studies of omega-3 supplements have been mixed, leaving both doctors and patients still wondering what to do.

Content restricted. Requires subscription

Beyond CBD: Here come the other cannabinoids, but where’s the evidence?

Given the interest in CBD and the exploding popularity (and big business) of products that contain it, it was only a matter of time before new cannabinoids were discovered and commercialized. But many of these substances have been studied only in animals so far, meaning it is too soon to say if any of their potential benefits will apply to humans.

Content restricted. Requires subscription